Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| Reactant | Methylamine hydrochloride | HCID 6364545 | — |
| Reactant | HCID 66730410 | HCID 66730410 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 46940978 | HCID 46940978 | 10.4% |
Reaction Steps
N-methyl-8-{4-[2-(tetrahydro-2H-pyran-4-yloxy)ethoxy]phenyl}-1,6-naphthyridine-2-carboxylic acid (281 mg, 0.71 mmol), an intermediate product of the synthetic process in Example 9 (9a), was dissolved in N,N-dimethylformamide (7 mL), to which methylamine hydrochloride (478 mg, 7.13 mol), triethylamine (1.2 mL, 8.56 mmol), 1-hydroxybenzotriazole (33 mg, 0.21 mmol), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (681 mg, 3.56 mmol) were added, followed by stirring at room temperature for 48 hours. The resulting reaction liquid was filtered and concentrated under reduced pressure. The residue thus obtained was purified by silica gel column chromatography (hexane:ethyl acetate, 40:60-0:100, V/V) to give the desired title compound (30 mg, yield 10%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08410273B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-b143e5c11bdd48088b0fa19b4beb743a |
|---|
| Source note | uspto-grants-2013_04 |
|---|